-
Mashup Score: 0
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation
Source: jtd.amegroups.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Percutaneous Management of Breast Cancer: a Systematic Review - Current Oncology Reports - 2 year(s) ago
Purpose of Review Surgical treatment of breast cancer is becoming increasingly more minimally invasive. We review the development status of percutaneous management for primary breast cancer and the evidence relating to tumor size as a fundamental determinant of treatment clinical outcome. Recent Findings It is safe and feasible for percutaneous management to treat breast cancer. For tumor size ≤…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors
Source: jtd.amegroups.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in the Journal of Thoracic Disease! 3rd of 4 articles on how to decide b/t various treatments when seeing a patient w/stage 1 #NSCLC in clinic. Great multidisciplinary collaboration! #lungcancer @YaleCancer @YaleMed @SmilowCancer @Yale_IR https://t.co/wWDSKabRV0 https://t.co/dpvpaeA16f
-
-
Mashup Score: 3
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients
Source: jtd.amegroups.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in the Journal of Thoracic Disease! 2nd of 4 articles on how to decide b/t various treatments when seeing a patient w/stage 1 #NSCLC in clinic. Great multidisciplinary collaboration! #lungcancer @YaleCancer @YaleMed @SmilowCancer @YNHH https://t.co/RaBgjpVwWE https://t.co/jIqmOoGPAZ
-
-
Mashup Score: 4SIR 2022 - 2 year(s) ago
Future liver remnant (FLR) size and function is a critical limiting factor for treatment eligibility and postoperative prognosis when considering surgical hepatectomy. Preoperative portal vein embolization (PVE) has proven effective in modulating FLR and is now widely accepted as the gold standard. However, PVE is not always effective due to potentially inadequate FLR augmentation and tumor…
Source: www.sirmeeting.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Purpose of Review Minimal invasive procedures, including targeted biopsy (TB) and focal therapy (FT), are increasingly used in diagnosis and treatment of localized prostate cancer. Here, we review the current role of these procedures, from a perspective of an interventional radiologist. Recent Findings TB is an established part of current guidelines for diagnosis of PCa. Several modalities of FT…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in Current Oncology Reports! Superb article by Dr. Jurgen Fütterer's team from @radboudumc & Shamir Med Ctr on the #irad perspective to diagnose & treat localized #prostatecancer w/minimally invasive techniques! @SIRspecialists @SIR_ECS https://t.co/3Y8yoeYtqL https://t.co/xnV5vMFo0M
-
-
Mashup Score: 0
A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-making
Source: jtd.amegroups.comCategories: Latest Headlines, Oncologists2Tweet-
Hot off the press in the Journal of Thoracic Disease! First of 4 articles on how to decide b/t various treatments when seeing a patient w/stage 1 #NSCLC in clinic. Great multidisciplinary collaboration! #lungcancer @YaleCancer @YaleMed @SmilowCancer @YNHH https://t.co/nRZ1cYhTWw https://t.co/8fODg5j4my
-
-
Mashup Score: 2
Purpose of Review Thermal ablation presents a therapeutic option other than active surveillance and immediate surgery for patients with low-risk papillary thyroid microcarcinomas (PTMC). Here, we have reviewed the current oncologic outcome of thermal ablation in PTMC cases and compared it with active surveillance and surgery. Recent Findings Thermal ablation in PTMC cases revealed no tumor…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in Current Oncology Reports! Excellent review by @radbaek et al from @AsanMedicalCtr on role of thermal ablation to manage patients w/papillary #thyroidcancer. Extremely beneficial yet underutilized procedure in Western countries! #irad https://t.co/dgffg9SrXE https://t.co/sJRzltedjB
-
-
Mashup Score: 2Role of Image-Guided Percutaneous Needle Biopsy in the Age of Precision Medicine - Current Oncology Reports - 3 year(s) ago
Purpose of review With the remarkable progress in cancer precision medicine, the demand for biopsy has been increasing, and the role of biopsy has been changing. In this review, we discuss the current state and recent advances in the role of image-guided percutaneous needle biopsy (PNB) in facilitating precision medicine. Recent findings Biopsies are useful not only in the diagnosis of cancer and…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4
Purpose of Review Based on good local control rates and an excellent safety profile, guidelines consider thermal ablation the gold standard to eliminate small unresectable colorectal liver metastases (CRLM). However, efficacy decreases exponentially with increasing tumour size. The preferred treatment for intermediate-size unresectable CRLM remains uncertain. This systematic review and…
Source: SpringerLinkCategories: Hem/Oncs, Latest HeadlinesTweet-
Hot off the press in Current Oncology Reports & just in time for #ColorectalCancerAwarenessMonth! A systematic review & meta-analysis that shows focal ablative therapy is safe & effective for unresectable #colorectalcancer liver metastases 3-5 cm in size. https://t.co/jQhzPLhxhT https://t.co/R0WuCJ0h4j
-
Hot off the press in the Journal of Thoracic Disease! 4th of 4 articles on how to decide b/t various treatments when seeing a patient w/stage 1 #NSCLC in clinic. Great multidisciplinary collaboration! #lungcancer @YaleCancer @YaleMed @SmilowCancer @Yale_IR https://t.co/K316kSEGcd https://t.co/eTRNm94qmQ